+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Colon Cancer"

From
Oncology Nutrition - Global Strategic Business Report - Product Thumbnail Image

Oncology Nutrition - Global Strategic Business Report

  • Report
  • May 2024
  • 352 Pages
  • Global
From
From
From
Precision Medicine in Oncology. Edition No. 1 - Product Thumbnail Image

Precision Medicine in Oncology. Edition No. 1

  • Book
  • October 2020
  • 288 Pages
  • 18 Results (Page 1 of 1)
Loading Indicator

Colon cancer is a type of cancer that affects the large intestine, or colon. It is the third most common type of cancer in the world and is the second leading cause of cancer-related deaths in the United States. In oncology, colon cancer is typically treated with a combination of surgery, chemotherapy, and radiation therapy. Surgery is the most common treatment, and it is used to remove the tumor and any affected lymph nodes. Chemotherapy and radiation therapy are used to kill any remaining cancer cells. The colon cancer market is a rapidly growing segment of the oncology market. It is driven by the increasing prevalence of the disease, advances in treatment options, and the availability of new drugs. Companies in the market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, and Roche. Show Less Read more